MLLT3 and acute myeloid leukemia: CaSR-deficient MLL-AF9+ cells in AML were characterised by a significant increase of cells in the G1 and a reduction of cells in the S phase of the cell cycle (Supplementary Fig. 11e), as well as increased apoptosis compared to WT counterparts (Supplementary Fig. 11f).